Skip to main content

Articles

FDA Approvals, In the News, Lung Cancer, Oncology
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Read More
FDA Approvals, In the News
March 08, 2019 - FDA Approvals, News & Updates
Read More
Practice Management
Economic Implications of Inpatient versus Outpatient Autologous Transplant for Patients with Multiple Myeloma
Chase Doyle
Read More
Practice Management
Inpatient Costs for Children and Young Adults with Acute Lymphoblastic Leukemia Higher at Specialized Cancer Centers, but for a Good Reason?
Chase Doyle
Read More
In the Literature, Oncology
Ibrutinib Superior to Standard Chemoimmunotherapy in Older Patients with CLL
Read More
In the Literature, Oncology
Olaparib Maintenance Extends Progression-Free Survival in Advanced Ovarian Cancer
Read More
In the Literature, Oncology
Tisagenlecleucel Leads to High Rates of Durable Response in Relapsed, Refractory DLBCL
Read More
Oral Rigosertib plus Azacitidine Combination Shows Promising Results in High-Risk Myelodysplastic Syndromes
Chase Doyle
Read More
Luspatercept, First-in-Class Erythroid Maturation Agent, Reduces Transfusions in Patients with Low-Risk Myelodysplastic Syndromes
Wayne Kuznar
Read More
Page 57 of 244
Results 561 - 570 of 2434